Does IBRUTINIB Cause Metastatic neoplasm? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Metastatic neoplasm have been filed in association with IBRUTINIB (Imbruvica). This represents 0.0% of all adverse event reports for IBRUTINIB.
20
Reports of Metastatic neoplasm with IBRUTINIB
0.0%
of all IBRUTINIB reports
9
Deaths
8
Hospitalizations
How Dangerous Is Metastatic neoplasm From IBRUTINIB?
Of the 20 reports, 9 (45.0%) resulted in death, 8 (40.0%) required hospitalization.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
Which IBRUTINIB Alternatives Have Lower Metastatic neoplasm Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE